Bellwether Bio is a Seattle-based startup developing a novel bioinformatics approach to analyze circulating cell-free DNA. First unveiled in a January 2016 Cell paper, technology was
Real-time cancer cell visualization for surgical applications. Blaze is working to develop Tumor Paint products and Optide*-based guided therapeutics.
Cancer Targeted Technology develops innovative agents for cancer that accurately detect early and advanced disease, monitor treatment efficacy
Circulating tumor cell detection
CellSight's makes imaging tools to assess the response to immunotherapy..
Cynvenio is a cancer diagnostics company focused on transforming cancer treatment and management through the molecular analysis of cancer biomarkers in blood.
Molecular Diagnostics. Develops and commercializes innovative molecular diagnostic tests that address unmet needs in cancer screening, diagnosis and patient management.
Foundation Medicine is leading a transformation in cancer care, where each patient’s treatment is informed by a deep understanding of the molecular changes that contribute to their disease.
Genome Explorations, a subsidiary of Compass Laboratory Services, LLC., is a premier research institution providing global genomic profiling and molecular diagnostics. We serve academic centers, ...
At Inspirata®, our focus is to advance the practice of pathology with solutions leveraging 21st century tools and technologies that are purpose built to accelerate cancer ...
NantOmics employs a comprehensive, integrated panomic approach to detect molecular alterations in individual tumors and inform personalized treatment options for patients with cancer. Whole genome ...
Molecular Diagnostics with a focus on the early and highly accurate detection of cancer
OmniSeq was created from the Center for Personalized Medicine at Roswell Park Cancer Institute and is a CLIA and NYS CLEP licensed molecular laboratory that is committed to improving access to the ...
Cellular Screening for Cancer Diagnosis
An oncology company that is pioneering a novel approach to evaluating patient response to drugs in clinical trials.
Resolution Bioscience uses Next Generation DNA sequencing, bioinformatics, and biochemistry to measure circulating, cell-free DNA (cfDNA) for cancer diagnostics and monitoring.
Breast cancer diagnostic
TOMA has commercially launched TOMA OS-SeqTM Cancer Assay to help laboratories and researchers uncover clinically meaningful genomic changes in tumors, including many missed by other ...
Skin Cancer Detection
diagnostic and therapeutic products for oncology